Direct morphological evidence of neuroimmunomodulation in colonic mucosa of patients with crohn’s disease

NeuroImmunoModulation

Volumn 4, Issue 5-6, 1997, Pages 250-257

  Fehér, Erzsébet ^a   Kovács, Ágota ^c   Gallatz, Katalin ^a   Fehér, János ^b  

^a Histology and Embryology ^*  (Hungary)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^c First Dept of Internal Medicine   (Hungary)

Author keywords

Colon; Crohn s disease; Neuropeptides

Indexed keywords

MESALAZINE; NEUROPEPTIDE; SOMATOSTATIN; STEROID; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; MALE; NERVE ENDING; PRIORITY JOURNAL; SYNAPSE VESICLE;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AUTOIMMUNE DISEASES; COLON; CROHN DISEASE; ENKEPHALIN, LEUCINE; ENTERIC NERVOUS SYSTEM; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL MUCOSA; MALE; MESALAMINE; MIDDLE AGED; NERVE FIBERS; NEUROIMMUNOMODULATION; NEUROPEPTIDE Y; PLASMA CELLS; SOMATOSTATIN; STEROIDS; SUBSTANCE P; SYNAPSES; VASOACTIVE INTESTINAL PEPTIDE;

EID: 13144249213     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000097344     Document Type: Article

References (51)

1. Whitehead R: Pathology of Crohn’s disease of the colon; in Kirsner JB, Shorter RG (eds): Inflammatory' Bowel Disease, Philadelphia, Lea & Febigcr, 1975. pp 182-198.
2. Morsoti BC, Dawson IMP: Inflammatory disorders; in Morsoti BC, Dawson IMP (eds): Gastrointestinal Pathology, Oxford, Blackwell Scientific Press, 1982. pp 243-298.
3. Dvorak AM, Osage JE, Monahan RA, Dickcr-sin GR: Crohn’s disease: Transmission electron microscopic studies, 111. Target tissues, Proliferation of an injury to smooth muscle and the autonomic nervous system, Hum Pathol 1980;11:620-634.
4. Szabô V, Fehér E: Ultrastructural changes in the nerve elements in Crohn’s disease, Acta Chir Hung 1991;32:25-32.
5. Bishop AE, Polak JM, Bryant MG, Bloom SR, Hamilton S: Abnormalities of vasoactive intestinal polypeptide-containing nerves in Crohn's disease, Gastroenterology 1980;79:853-860.
6. O'Marain C, Bishop AE, McGregor GP, Levi AJ, Bloom SR, Polak JM, Peters TJ: Vasoactive intestinal polypeptide concentrations and immunocytochemical studies in rectal biopsies from patients with inflammatory bowel disease, Gut 1984;25:57-61.
7. Sjôklund K, SchafTalitzky de Muckadcll OB, Fahrenkrug F, Hakanson R, Peterson BG, Sundler F: Peptide-containing nerve fibres in the gut wall in Crohn's disease, Gut 1983;24: 724-733.
8. Spaepen M, Van Gonipel A, Bormans V, Peters TL, Van Trappen G: Vasoactive intestinal polypeptide (VIP), somatostatin and substance P concentrations in colonic biopsies from patients with Crohn's disease of the colon, Dig DisSci 1984;29:825-832.
9. Schmitz-Reinhardt B, Lohsc AW, Arnold R: VIP tissue content in colonic biopsies from normal patients compared with Crohn's disease and ulcerative colitis, Regul Pcpt 1985; 3(suppl):540.
10. Kubota Y, Petras RE, Ottaway CA, Tubbs RR, Farmer RG, Fiocchi S: Colonic vasoactive intestinal peptide nerves in inflammatory bowel disease, Gastrocnterolgy 1992:102:1242- 1251.
11. Mazumdar S, Das KM: Immunocyioehemical localization of vasoactive intestinal peptide and substance P in the colon from normal subjects and patients with inflammatory bowel disease, Am J Gastroenterol 1992:S7:176- 181.
12. Kimura M, Masuda T, Hiwatashi N, Toyota T, Nagura H: Changes in neuropeptide-containing nerves in human colonic mucosa with inflammatory bowel disease, Pathol Ini 1994:44: 624-634.
13. Koch TR, Carney JA, Go VLW: Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases, Dig DisSci 1987:32:369-376.
14. Payan DG, Brewster DR, Goetzl EJ: Specific stimulation of human T lymphocytes by substance P, J Immunol 1983:131:1613-1615.
15. Payan DG, Goetzl EJ: Modulation of lymphocyte formation by sensory neuropeptides, J Immunol 1985; 135:783S-786S
16. Fink T, Weihc E: Multiple neuropeptides in nerves supplying mammalian lymph nodes: Messenger candidates for sensory and autonomic neuroimmunomodulation, Ncurosci Lett 1988:90:39-44.
17. Elitsur Y, Luck GD: Gastrointestinal neuropeptides suppress human colonic lamina propria lymphocytes DNA synthesis, Peptides 1990; 11:879-884.
18. Muscettola M, Grasso G: Somatostatin and vasocactive intestinal peptide reduce interferon gamma production by human peripheral blood mononuclear cells, Immunobiology 1990;180:419-430.
19. Pawlikowski M, Zelazowski P, Stepien H, Schally AV: Somatostatin and its analog enhance the formation of human leukocyte migration inhibition factor: Further evidence for immunomodulatory action of somatostatin, Peptides 1987;8:951-952.
20. Roda LG, Bongiamo L, Trani E, Urbani A, Marini M: Positive and negative immunomo-dulation by opioid peptides, Int J Immuno-pharmaco 1996;18:1-16.
21. Schreiber S, Racdlcr A, Stenson WF, MacDer-niott RP: The role of the mucosal immune system in inflammatory bowel disease, Gastroenterol Clin North Am 1992:21:451-502.
22. Lauritsen K, Laursen LS, Kjeldsen J, Bukhav-cn K, Rask-Mdscn J: Actions of sulphasalazine and analogues on mucosal cicosanoid formation and metabolism in patients with ulcerative colitis, Inflammopharmacology 1993:2:233-245.
23. Gionchctti P, Guamicri C, Campicri M, Bel-luzzi A, Brignola C, lannone P, Miglioli M, Barbara L: Scavenger effect of sulfasalizinc, 5-aminosalicylic acid, and olsalazine on superoxide radical generation, Dig Dis Sei 1991:36: 174-178.
24. Riley SA, Mani V, Goodman MJ, Dull S, Herd ME: Microscopic activity in ulcerative colitis: What docs it mean, Gut 1991:32:174-178.
25. Lantos TL, Göres TJ, Palkovits M: Immuno-histochemieal mapping of neuropeptides in the prcmamillary region of the hypothalamus in rats, Brain Res Rev 1995:20:209-249.
26. Nagel E, Schattenfroh S, Buhner S, Bartels M, Guthv E, Pichlmayr R: Animal experiment studies of ultrastructural changes in the lamina propria of the ileum caused by dietary fats and comparison with cytopalhology in Crohn's disease, Z Gastroenterol 1993:31:727-734.
27. Nielsen OH, Rask-Machsen J: Mediators of inflammation in chronic inflammatory bowel disease, Scand J Gastroenterol 1996:31:149- 159.
28. Cooke H: Neurobiology of the intestinal mucosa, Gastroenterology 1986:90:1057- 1061
29. Morlcv JE, Kav N: Neuropeptides as modulators of immune function, Psychopharmacol Bull 1986;22:1089-1092.
30. Payan DG, Brewster DR, Missirlan-Bastian A, Goetzl EJ: Substance P recognition by a subset of human T lymphocytes, J Clin Invest 19S4; 74:1532-1539.
31. Nordling K, Mutt V: Modulating effect ofbeta-endorphin, somatostatin, substance P and vasoactive intestinal peptide on the proliferation response of peripheral blood T lymphocytes of nickel-allergic patients to nickel sulfate, Int Arch Allergy Appl Immunol 1986:81:368-370.
32. O'Dorisio MS, Wood CL, O’Dorisio TM: Vasoactive intestinal peptide and neuropeptide modulation of the immune response, J Immunol 1985;135:792-796.
33. McGillis JP, Organist ML, Payan DG: Substance P and inimunorcgulation, Fed Proc 1987:46:196-199.
34. Annibale B, Fals S, Bairivant M, Fave GD, Pal-lone F: Effects of high in vivo levels of vasoactive intestinal polypeptide on function of circulating lymphocytes in humans, Gastroenterology 1990;98:1693-1698.
35. Bajpai K, Singh VK, Dhawan VK, Hag W, Mathur KB, Agarwal SS, Immunomodulation by two potent analogs of mel-cnkephalin, Im-munopharmacology 1997:35:213-220.
36. Johnston JA, Taub DP, Lloyd AR, Conlon K, Oppenheim JJ, Kcvlin DJ: Human T lymphocyte Chemotaxis and adhesion induced by vasoactive intestinal polypeptide, J Immunol 1994:153:1762-1768.
37. Mantvh CR, Vigna SR, Bollinger RR, Mantyh PW, Maggio JE, Pappas TN: Differential expression of substance P receptors in patients with Crohn’s disease and ulcerative colitis, Gastroenterology 1995:109:850-860.
38. Berman AS, Chancellor-Freeland C, Zhu G, Black PH: Substance P primes murine peritoneal macrophages for an augmented proinflam-matory cytokine response to lipopolvsaccha-ride, Neuroimmunomodulation 1996:3:141-149.
39. Calam J, Ghatci MA, Domin J, Adrian TE, Myszor M, Gupta S, Tait C, Bloom SR: Regional differences in concentrations of regulatory peptides in human colon mucosal biopsy, Dig DisSci 1989:34:1193-1198.
40. Stead RH, Dixon MF, Bramwell NIL, Riddell RH, Bienenstock J: Mast cells are closely apposed to nerves in the human gastrointestinal mucosa, Gastroenterology 1959:97:575-585.
41. Frieling T, Strohmeycr G: Neuroimmune Interaktionen im Gastrointestinaltrakt, Z Gastroenterol 1995:33:219-224.
42. Theoharides TC: The mast cell: A neuroimmu-noendocrinc master player, Int J Tissue React 1996:18:1-21.
43. Aloe L, Skaper SD, Leon A, Lcvi-Montalcini R: Nerve growth factor and autoimmune diseases, Autoimmunity 1994:19:141-150.
44. Fierling T, Palmer JM, Cooke HJ, Wood JD: Neuroimmune communication in the submu-cous plexus of guinea-pig colon after infection with Tricliinella spiralis, Gastroenterology 1994:107:1602-1609.
45. MacDermoll RP, Schloemann SR, Bertovich MJ: Inhibition of antibody synthesis by 5-ami-nosalicvlic acid, Gastroenterology 1989:96: 442-445
46. Schrcibcr S, Nash GS, Racdler A: 1 luman lamina propria mononuclear cells are activated in inflammatory bowel disease: in Tsuchiya M (ed): Frontiers of Mucosal Immunology, Amsterdam, Elsevier, 1991. pp 749-753.
47. Leonard N, Hourhanc DOB, Whelan A: Neuroproliferation in the mucosa is a feature of cocliae disease and Crohn’s disease, Gut 1995; 37:763-765.
48. Croitoru K, Ernest PB, Stanisz AM, Stead RII, Bienenstock J: Neuropeptide regulation of mucosal immune system: in Tragan SR, Shanahan F (eds): Immunology and Immunopathology of the Liver and Gastrointestinal Tract, New York, Igaku-Shoin, 1990. pp 183-201.
49. Fchcr E, Fodor M, Burnstock G: Distribution of somatostatin-immunoreactivc nerve fibres in Pcycr's patches, Gut 1992:33:1195-1198
50. Ottaway CA: Neuroimmunomodulation in the intestinal mucosa, Gastroenterol Clin North Am 1991:20:511-529.
51. Hori T, Kalafuchi T, Take S, Shimizu N, Niiji-ma A: The autonomic nervous system as a communication channel between the brain and the immune system, Neuroimmunomodulation 1995:2:203-215.